Norveġja -
Norveġiż -
Statens legemiddelverk
spersallerg 0.5 mg/ ml / 0.4 mg/ ml
laboratoires théa s.a.s - antazolinhydroklorid / tetryzolinhydroklorid - Øyedråper, oppløsning med konserveringsmiddel - 0.5 mg/ ml / 0.4 mg/ ml
Unjoni Ewropea -
Norveġiż -
EMA (European Medicines Agency)
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiske midler - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
Unjoni Ewropea -
Norveġiż -
EMA (European Medicines Agency)
rybrevant
janssen-cilag international n.v. - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
Norveġja -
Norveġiż -
Statens legemiddelverk
tektrotyd 20 mikrog
narodowe centrum badán jadrowych - hynic-[d-phe1,tyr3-oktreotid] trifluoracetat - preparasjonssett til radioaktive legemidler - 20 mikrog
Norveġja -
Norveġiż -
Statens legemiddelverk
accofil 30 mill e/0.5 ml
2care4 aps - filgrastim - injeksjons-/infusjonsvæske, oppløsning i ferdigfylt sprøyte - 30 mill e/0.5 ml